Cellular Origins
PrivateLast Round
Series A
Dec 9, 2025
Total Funding Raised
$40M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cellular Origins operates in Healthcare & Life Sciences and is based in Melbourn. Its latest recorded funding round was a Series A round in December 2025.
Cellular Origins is a biotechnology company that provides a robotic automation platform, Constellation, designed for the scalable, cost-effective, and efficient manufacture of cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Industrial Robotics, Smart Manufacturing, Workflow Automation
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellular Origins Comparables
Compare Cellular Origins with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ori Biotech | 87% | |
| Multiply Labs | 86% | |
| Cellares | 83% |
For institutional investors. Book with your work email.
Cellular Origins Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellular Origins Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TTP Group | Series A |
| BGF | Series A |
| Johnson & Johnson Innovation – JJDC | Series A |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
| NYBC Ventures | Series A |
| Highland Europe | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2026
Maintains ISO 9001 certification for its Quality Management System.
- Sep 11, 2026
Monthly visitors increased 85% MoM, from 2.4K to 4.5K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 28, 2026
Cellular Origins Ltd. is developing a scalable, robotic system for cell therapy manufacturing that is intended to fit existing or new facilities and use autonomous mobile robots, sterile tube welding, and unified software orchestration.
For institutional investors. Book with your work email.
Cellular Origins Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellular Origins's valuation, stock price, and market status.
Is Cellular Origins a public or private company?
Cellular Origins is a private company.
What is the current stock price of Cellular Origins?
Cellular Origins is a private company, so its shares have no public market price. Caplight tracks Cellular Origins's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellular Origins worth (valuation)?
Valuation information for Cellular Origins is not publicly available.
Can I buy Cellular Origins stock?
Cellular Origins shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellular Origins's last funding round?
Cellular Origins's most recent funding round was Series A on December 9, 2025.
Who are the main investors in Cellular Origins?
Key investors in Cellular Origins include Johnson & Johnson Innovation – JJDC, Johnson & Johnson Innovation - JJDC, Inc..
Will Cellular Origins IPO soon?
No public IPO plans have been announced for Cellular Origins.
How can I track Cellular Origins secondary market activity?
Caplight tracks bids, offers, and trades in Cellular Origins's shares on secondary markets.